Pfiz­er, Bris­tol My­ers dom­i­nate top 10 pre­dic­tions for the best-sell­ing drugs of 2022

The an­nu­al ex­er­cise where an­a­lysts try and pre­dict which drugs will be­come block­busters and make the most mon­ey tends to high­light the biggest trends in bio­phar­ma R&D. 2022 is no ex­cep­tion.

The team at Eval­u­ate Van­tage pub­lished its pre­dic­tions for the top 10 sell­ing drugs for the year — ex­pect­ing tens of bil­lions of dol­lars in sales and high­light­ing an in­dus­try-wide fo­cus on cer­tain dis­eases and in­di­ca­tions.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.